Selected signalling proteins recruited to the T-cell receptor–CD3 complex

Immunology

Volumn 153, Issue 1, 2018, Pages 42-50

  Ngoenkam, Jatuporn ^a   Schamel, Wolfgang W ^b,c   Pongcharoen, Sutatip ^a  

^a NARESUAN UNIVERSITY   (Thailand)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

protein protein interaction; signal transduction; T cell activation; T cell receptor CD3 complex

Indexed keywords

CD3 ANTIGEN; NCK PROTEIN; NUMB PROTEIN; PROTEIN; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; WASP PROTEIN; CARRIER PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; NERVE PROTEIN; NUMB PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN BINDING; SIGNAL TRANSDUCING ADAPTOR PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN;

AUTOIMMUNE DISEASE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; PROTEIN DOMAIN; T LYMPHOCYTE SUBPOPULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARRIER PROTEINS; CD3 COMPLEX; HUMANS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MEMBRANE PROTEINS; MUTATION; NERVE TISSUE PROTEINS; ONCOGENE PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; WISKOTT-ALDRICH SYNDROME PROTEIN; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 85037703109     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12809     Document Type: Review

References (96)

1. Brownlie RJ, Zamoyska R. T cell receptor signalling networks: branched, diversified and bounded. Nat Rev Immunol 2013; 13:257–69.
2. Acuto O, Di Bartolo V, Michel F. Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Nat Rev Immunol 2008; 8:699–712.
3. Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity 2013; 38:633–43.
4. Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol 2009; 27:591–619.
5. Kane LP, Lin J, Weiss A. Signal transduction by the TCR for antigen. Curr Opin Immunol 2000; 12:242–9.
6. Jacobs H. Pre-TCR/CD3 and TCR/CD3 complexes: decamers with differential signalling properties? Immunol Today 1997; 18:565–9.
7. Alarcón B, Gil D, Delgado P, Schamel WW. Initiation of TCR signalling: regulation within CD3 dimers. Immunol Rev 2003; 191:38–46.
8. Dong G, Kalifa R, Nath PR, Gelkop S, Isakov N. TCR crosslinking promotes Crk adaptor protein binding to tyrosine-phosphorylated CD3ζ chain. Biochem Biophys Res Commun 2017; 488:541–6.
9. Love PE, Hayes SM. ITAM-mediated signaling by the T-cell antigen receptor. Cold Spring Harb Perspect Biol 2010; 2:a002485.
10. de Aós I, Metzger MH, Exley M, Dahl CE, Misra S, Zheng D et al. Tyrosine phosphorylate ion of the CD3-ε subunit of the T cell antigen receptor mediates enhanced association with phosphatidylinositol 3-kinase in Jurkat T cells. J Biol Chem 1997; 272:25310–8.
11. DeFord-Watts LM, Young JA, Pitcher LA, van Oers NS. The membrane-proximal portion of CD3ε associates with the serine/threonine kinase GRK2. J Biol Chem 2007; 282:16126–34.
12. Delgado P, Cubelos B, Calleja E, Martínez-Martín N, Ciprés A, Mérida I et al. Essential function for the GTPase TC21 in homeostatic antigen receptor signalling. Nat Immunol 2009; 10:880–8.
13. Borrotto A, Abia D, Alarcon B. Crammed signaling motifs in the T-cell receptor. Immunol Lett 2014; 161:113–7.
14. Morris GP, Allen PM. How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat Immunol 2012; 13:121–8.
15. von Boehmer H, Melchers F. Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 2010; 11:14–20.
16. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003; 426:454–60.
17. + thymic selection in humans lacking zap-70 kinase. Cell 1994; 76:947–58.
18. Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A et al. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 1994; 264:1596–9.
19. Roifman CM, Dadi H, Somech R, Nahum A, Sharfe N. Characterization of ζ-associated protein, 70 kd (ZAP70)-deficient human lymphocytes. J Allergy Clin Immunol 2010; 126:1226–33.
20. Wu J, Liu D, Tu W, Song W, Zhao X. T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott–Aldrich syndrome. J Allergy Clin Immunol 2015; 135:209–16.
21. Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H. The role of the T cell in autoimmune inflammation. Arthritis Res Ther 2005; 7(Suppl 2):S4–14.
22. van Oers NS, Killeen N, Weiss A. Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J Exp Med 1996; 183:1053–62.
23. Iwashima M, Irving BA, van Oers NS, Chan AC, Weiss A. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 1994; 263:1136–9.
24. Schröder AJ, Quehl P, Müller J, Samstag Y. Conversion of p56(lck) to p60(lck) in human peripheral blood T lymphocytes is dependent on co-stimulation through accessory receptors: involvement of phospholipase C, protein kinase C and MAP-kinases in vivo. Eur J Immunol 2000; 30:635–43.
25. Joung I, Kim T, Stolz LA, Payne G, Winkler DG, Walsh CT et al. Modification of Ser59 in the unique N-terminal region of tyrosine kinase p56lck regulates specificity of its Src homology 2 domain. Proc Natl Acad Sci USA 1995; 92:5778–82.
26. Rossy J, Williamson DJ, Gaus K. How does the kinase Lck phosphorylate the T cell receptor? Spatial organization as a regulatory mechanism. Front Immunol 2012; 3:167.
27. Boggon TJ, Eck MJ. Structure and regulation of Src family kinases. Oncogene 2004; 23:7918–27.
28. Filipp D, Ballek O, Manning J. Lck, membrane microdomains, and TCR triggering machinery: defining the new rules of engagement. Front Immunol 2010; 3:155.
29. Kim PW, Sun ZY, Blacklow SC, Wagner G, Eck MJ. A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8. Science 2003; 301:1725–8.
30. Nika K, Soldani C, Salek M, Paster W, Gray A, Etzensperger R, et al. Constitutively active Lck kinase in T cells drives antigen receptor signal transduction. Immunity 2010; 32:766–77.
31. Stirnweiss A, Hartig R, Gieseler S, Lindquist JA, Reichardt P, Philipsen L et al. T cell activation results in conformational changes in the Src family kinase Lck to induce its activation. Sci Signal 2013; 6:ra13.
32. Philipsen L, Reddycheria AV, Hartig R, Gumz J, Kastle M, Kritikos A et al. De novo phosphorylation and conformational opening of the tyrosine kinase Lck act in concert to initiate T cell receptor signaling. Sci Signal 2017; 10:pii: eaaf4736.
33. Xu H, Littman DR. A kinase-independent function of Lck in potentiating antigen-specific T cell activation. Cell 1993; 74:633–43.
34. Casas J, Brzostek J, Zarnitsyna VI, Hong JS, Wei Q, Hoerter JA et al. Ligand-engaged TCR is triggered by Lck not associated with CD8 coreceptor. Nat Commun 2014; 5:5624.
35. Rossy J, Owen DM, Williamson DJ, Yang Z, Gaus K. Conformational states of the kinase Lck regulate clustering in early T cell signalling. Nat Immunol 2013; 14:82–9.
36. Stefanová I, Hemmer B, Vergelli M, Martin R, Biddison WE, Germain RN. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat Immunol 2003; 4:248–54.
37. Chae HD, Siefring JE, Hildeman DA, Gu Y, Williams DA. RhoH regulates subcellular localization of ZAP-70 and Lck in T cell receptor signalling. PLoS One 2010; 5:e13970.
38. Straus DB, Chan AC, Patai B, Weiss A. SH2 domain function is essential for the role of the Lck tyrosine kinase in T cell receptor signal transduction. J Biol Chem 1996; 271:9976–81.
39. Sheng R, Jung DJ, Silkov A, Kim H, Singaram I, Wang ZG et al. Lipids regulate Lck protein activity through their interactions with the Lck Src homology 2 domain. J Biol Chem 2016; 291:17639–50.
40. Gil D, Schamel WW, Montoya M, Sánchez-Madrid F, Alarcón B. Recruitment of Nck by CD3ε reveals a ligand-induced conformational change essential for T cell receptor signalling and synapse formation. Cell 2002; 109:901–12.
41. Minguet S, Swamy M, Alarcon B, Luescher IF, Schamel WW. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Immunity 2007; 26:43–54.
42. Swamy M, Beck-Garcia K, Beck-Garcia E, Hartl FA, Morath A, Yousefi OS et al. A cholesterol-based allostery model of T cell receptor phosphorylation. Immunity 2016; 44:1091–101.
43. Kamens JS, Ratnofsky SE, Hirst GC. Lck inhibitors as a therapeutic approach to autoimmune disease and transplant rejection. Curr Opin Investig Drugs 2001; 2:1213–9.
44. Bhagwat SS. Kinase inhibitors for the treatment of inflammatory and autoimmune disorders. Purinergic Signal 2009; 5:107–15.
45. Waegell W, Babineau M, Hart M, Dixon K, McRae B, Wallace C et al. A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection. Transplant Proc 2002; 34:1411–7.
46. Burchat A, Borhani DW, Calderwood DJ, Hirst GC, Li B, Stachlewitz RF. Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection. Bioorg Med Chem Lett 2006; 16:118–22.
47. Maier JA, Brugel TA, Sabat M, Golebiowski A, Laufersweiler MJ, VanRens JC et al. Development of N-4,6-pyrimidine-N-alkyl-N’-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase. Bioorg Med Chem Lett 2006; 16:3646–50.
48. Chan AY, Punwani D, Kadlecek TA, Cowan MJ, Olson JL, Mathes EF et al. A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J Exp Med 2016; 213:155–65.
49. Wang H, Kadlecek TA, Au-Yeung BB, Goodfellow HE, Hsu LY, Freedman TS et al. ZAP-70: an essential kinase in T-cell signalling. Cold Spring Harb Perspect Biol 2010; 2:a002279.
50. Yan Q, Barros T, Visperas PR, Deindl S, Kadlecek TA, Weiss A et al. Structural basis for activation of ZAP-70 by phosphorylation of the SH2-kinase linker. Mol Cell Biol 2013; 33:2188–201.
51. Brdicka T, Kadlecek TA, Roose JP, Pastuszak AW, Weiss A. Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases. Mol Cell Biol 2005; 25:4924–33.
52. Klammt C, Novotná L, Li DT, Wolf M, Blount A, Zhang K et al. T cell receptor dwell times control the kinase activity of Zap70. Nat Immunol 2015; 16:961–9.
53. Di Bartolo V, Mège D, Germain V, Pelosi M, Dufour E, Michel F et al. Tyrosine 319, a newly identified phosphorylation site of ZAP-70, plays a critical role in T cell antigen receptor signalling. J Biol Chem 1999; 274:6285–94.
54. Williams BL, Irvin BJ, Sutor SL, Chini CC, Yacyshyn E, Bubeck Wardenburg J et al. Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-γ1 and Ras activation. EMBO J 1999; 18:1832–44.
55. Katz ZB, Novotná L, Blount A, Lillemeier BF. A cycle of Zap70 kinase activation and release from the TCR amplifies and disperses antigenic stimuli. Nat Immunol 2017; 18:86–95.
56. Tomlinson MG, Lin J, Weiss A. Lymphocytes with a complex: adapter proteins in antigen receptor signalling. Immunol Today 2000; 21:584–91.
57. Visperas PR, Wilson CG, Winger JA, Yan Q, Lin K, Arkin MR et al. Identification of inhibitors of the association of ZAP-70 with the T cell receptor by high-throughput screen. SLAS Discov 2017; 22:324–31.
58. Kaur M, Singh M, Silakari O. Insight into the therapeutic aspects of ‘Zeta-chain associated protein kinase 70 kDa’ inhibitors: a review. Cell Signal 2014; 26:2481–92.
59. Mukhopadhyay H, Cordoba SP, Maini PK, van der Merwe PA, Dushek O. Systems model of T cell receptor proximal signaling reveals emergent ultrasensitivity. PLoS Comput Biol 2013; 9:e1003004.
60. Guy CS, Vignali KM, Temirov J, Bettini ML, Overacre AE, Smeltzer M et al. Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nat Immunol 2013; 14:262–70.
61. Holst J, Wang H, Eder KD, Workman CJ, Boyd KL, Baquet Z et al. Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevent autoimmunity. Nat Immunol 2008; 9:658–66.
62. Lettau M, Pieper J, Janssen O. Nck adapter proteins: functional versatility in T cells. Cell Commun Signal 2009; 7:1.
63. Ngoenkam J, Paensuwan P, Preechanukul K, Khamsri B, Yiemwattana I, Beck-García E et al. Non-overlapping functions of Nck1 and Nck2 adaptor proteins in T cell activation. Cell Commun Signal 2014; 12:21.
64. Burkhardt JK, Carrizosa E, Shaffer MH. The actin cytoskeleton in T cell activation. Annu Rev Immunol 2008; 26:233–59.
65. Paensuwan P, Hartl FA, Yousefi OS, Ngoenkam J, Wipa P, Beck-Garcia E et al. Nck binds to the T cell antigen receptor using its SH3.1 and SH2 domains in a cooperative manner, promoting TCR functioning. J Immunol 2016; 196:448–58.
66. Kesti T, Ruppelt A, Wang JH, Liss M, Wagner R, Tasken K et al. Reciprocal regulation of SH3 and SH2 domain binding via tyrosine phosphorylation of a common site in CD3ε. J Immunol 2007; 179:878–85.
67. + thymocytes. Nat Immunol 2008; 9:522–32.
68. Borroto A, Arellano I, Dopfer EP, Prouza M, Suchanek M, Fuentes M et al. Nck recruitment to the TCR required for ZAP70 activation during thymic development. J Immunol 2013; 190:1103–12.
69. Vazquez ML. Biological consequences of the phosphorylation of serine 59 on the tyrosine kinase Lck. [PhD Thesis]. West Lafayette, IN: Purdue University; 2007.
70. Hem CD, Sundvold-Gjerstad V, Granum S, Koll L, Abrahamsen G, Buday L et al. T cell specific adaptor protein (TSAd) promotes interaction of Nck with Lck and SLP-76 in T cells. Cell Commun Signal 2015; 13:31.
71. Tailor P, Tsai S, Shameli A, Serra P, Wang J, Robbins S et al. The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signalling. J Immunol 2008; 181:243–55.
72. Morris GP, Allen PM. How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat Immunol 2012; 13:121–8.
73. Borrotto A, Reyes-Garau D, Jimenez MA, Carrasco E, Moreno B, Martinez-Pasamar S et al. First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases. Sci Transl Med 2016; 8:370ra184.
74. Takenawa T, Miki H. WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement. J Cell Sci 2001; 114:1801–9.
75. Vignesh P, Suri D, Rawat A, Lau YL, Bhatia A, Das A et al. Sclerosing cholangitis and intracranial lymphoma in a child with classical Wiskott–Aldrich syndrome. Pediatr Blood Cancer 2017; 64:106–9.
76. Miki H, Miura K, Takenewa T. N-WASP, a novel actin depolymerization protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J 1996; 15:5326–35.
77. Rohatgi R, Nollau P, Ho HY, Kirschner MW, Mayer BJ. Nck and phosphatidylinositol 4,5-bisphosphate synergistically activate actin polymerization through the N-WASP-Arp2/3 pathway. J Biol Chem 2001; 276:26448–52.
78. Zeng R, Cannon JL, Abramham RT, Way M, Billadeau DD, Bubeck-Wardenberg J et al. SLP-76 coordinates Nck-dependent Wiskott–Aldrich syndrome protein recruitment with Vav-1/Cdc42-dependent Wiskott–Aldrich syndrome protein activation at the T cell-APC contact site. J Immunol 2003; 171:1360–8.
79. Paensuwan P, Ngoenkam J, Khamsri B, Preechanukul K, Sanguansermsri D, Pongcharoen S. Evidence for inducible recruitment of Wiskott–Aldrich syndrome protein to T cell receptor–CD3 complex in Jurkat T cells. Asian Pac J Allergy Immunol 2015; 33:189–95.
80. Ferrandi C, Richard F, Tavano P, Huaben E, Barbie V, Gotteland JP et al. Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers. Mult Scler 2011; 17:43–56.
81. Yang M, Ye L, Wang B, Gao J, Liu R, Hong J et al. Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients 1miR-146. J Diabetes 2015; 7:158–65.
82. Gulino A, Di Marcotullio L, Screpanti I. The multiple functions of Numb. Exp Cell Res 2010; 316:900–6.
83. Aguado R, Martin-Blanco N, Caraballo M, Canelles M. The endocytic adaptor Numb regulates thymus size by modulating pre-TCR signaling during asymmetric division. Blood 2010; 116:1705–14.
84. Martin-Blanco N, Jimenez Teja D, Bretones G, Borroto A, Caraballo M, Screpanti I et al. CD3ε recruits Numb to promote TCR degradation. Int Immunol 2016; 28:127–37.
85. Borroto A, Lama J, Niedergang F, Dautry-Varsat A, Alarcón B, Alcover A. The CD3epsilon subunit of the TCR contains endocytosis signals. J Immunol 1999; 163:25–31.
86. Isakov N, Wange RL, Burgess WH, Watts JD, Aebersold R, Samelson LE. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity. J Exp Med 1995; 181:375–80.
87. Granum S, Sundvold-Gjerstad V, Gopalakrishnan RP, Berge T, Koll L, Abrahamsen G et al. The kinase Itk and the adaptor TSAd change the specificity of the kinase Lck in T cells by promoting the phosphorylation of Tyr192. Sci Signal 2014; 7:ra118.
88. D'Oro U, Sakaguchi K, Appella E, Ashwell JD. Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol Cell Biol 1996; 16:4996–5003.
89. Wu J, Zhao Q, Kurosaki T, Weiss A. The Vav binding site (Y315) in ZAP-70 is critical for antigen receptor-mediated signal transduction. J Exp Med 1997; 185:1877–82.
90. Deindl S, Kadlecek TA, Cao X, Kuriyan J, Weiss A. Stability of an autoinhibitory interface in the structure of the tyrosine kinase ZAP-70 impacts T cell receptor response. Proc Natl Acad Sci USA 2009; 106:20699–704.
91. Chan AC, Dalton M, Johnson R, Kong GH, Wang T, Thoma R et al. Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J 1995; 14:2499–508.
92. Miyoshi-Akiyama T, Aleman LM, Smith JM, Adler CE, Mayer BJ. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor. Oncogene 2001; 20:4058–69.
93. Lettau M, Kliche S, Kabelitz D, Janssen O. The adaptor proteins ADAP and Nck cooperate in T cell adhesion. Mol Immunol 2014; 60:72–9.
94. Silvin C, Belisle B, Abo A. A role for Wiskott–Aldrich syndrome protein in T-cell receptor-mediated transcriptional activation independent of actin polymerization. J Biol Chem 2001; 276:21450–7.
95. Jain N, Tan JH, Feng S, George B, Thanabalu T. X-linked thrombocytopenia causing mutations in WASP (L46P and A47D) impair T cell chemotaxis. J Biomed Sci 2014; 21:91.
96. Anderson AC, Kitchens EA, Chan SW, St Hill C, Jan YN, Zhong W et al. The Notch regulator Numb links the Notch and TCR signaling pathways. J Immunol 2005; 174:890–7.